Comparison of the effects of monotherapy with exenatide or metformin to combined exenatide and metformin therapy on menstrual cyclicity in overweight women with polycystic ovary syndrome
Phase of Trial: Phase II
Latest Information Update: 18 Aug 2012
At a glance
- Drugs Exenatide; Metformin
- Indications Obesity; Polycystic ovary syndrome; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 07 Sep 2008 Results presented at the 44th Annual Meeting of the European Association for the Study of Diabetes.
- 11 Jul 2007 Status change from in progress to completed.